The Food and Drug Administration (FDA) ordered a recall Tuesday of Taiwan's most widely used lipid-lowering drug after more counterfeit versions of the drug were found.
Japan's top pharmaceutical company Takeda said it is buying a U.S. cancer drugmaker for US$5.2 billion, as its top executive left the door open to more overseas acquisitions.
Dominique was hooked on cocaine and smoked two packs of cigarettes a day until she stumbled onto ayahuasca, a hallucinogenic concoction that she says has changed her life.
A U.S. jury has ordered pharmaceutical giant Gilead Sciences to pay US$2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.
A new study gives some reassurance to arthritis sufferers who want pain relief but are worried about side effects. It finds that Celebrex, a drug similar to ones withdrawn 12 years ago for safety reasons, is no riskier for the heart than some other prescription pain pills that are much tougher on the stomach.
Top GlaxoSmithKline (GSK) executives have said the days of pharmaceutical companies paying doctors to educate their peers about a brand's products look set to change, with other big drugmakers ready to follow the firm's lead in reforming how medicine is marketed to health care professionals.
As the investigation into Prince's death homes in on the source of the fatal fentanyl, some observers are suggesting that the United States explore a lifesaving strategy used in Europe: services that check addicts' drug supplies to see if they are safe.
Health officials warn that electronic cigarettes and other vaping devices are poisoning kids with nicotine.
The first new asthma pill in nearly 20 years has led to a sharp improvement in symptoms for chronic sufferers of the disease, according to an early test of the drug.
Three different experimental Zika vaccines being developed in the United States have worked well in monkey studies, paving the way for human trials in the coming months, researchers said Thursday.